• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Spruce Biosciences Inc (NQ: SPRB )

    0.4743 +0.0114 (+2.46%)
    Streaming Delayed Price Updated: 10:26 AM EDT, Aug 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Spruce Biosciences Inc

    < Previous 1 2 3 4 5 6 7 Next >
    SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
    SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
    From Spruce Biosciences, Inc.
    Via Business Wire
    Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
    Via AB Newswire
    Spruce Biosciences Recognized as a Bay Area Best Place to Work
    From Spruce Biosciences, Inc.
    Via Business Wire
    Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
    Spruce Biosciences collaborates with HMNC Brain Health to advance tildacerfont, a precision therapeutic for major depressive disorder, using the Cortibon Genetic Selection Tool. 
    Via Benzinga
    Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
    From Spruce Biosciences, Inc.
    Via Business Wire
    SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
    SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences to Participate in May Investor Conferences
    From Spruce Biosciences, Inc.
    Via Business Wire
    Pfizer Q1 Earnings and Revenues Beat Estimates
    PFE came out with quarterly earnings of $0.82 per share, beating the our eimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago. 
    Via Talk Markets
    Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
    Spruce Biosciences faces setbacks as tildacerfont trials fail primary endpoints, raising concerns about drug efficacy and compliance. Analysts downgrade ratings and adjust price targets amid... 
    Via Benzinga
    Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
    U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to 38,905.20 while the NASDAQ fell 0.13% to 16,156.28.... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
    U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.30% to 38,926.22 while the NASDAQ fell 0.44% to 16,107.04. The... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    US Stocks Higher; Producer Prices Rise 0.6% In February
    U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
    Anheuser-Busch stock is falling on Thursday following news that 10% holder Altria is selling a portion of its stake in BUD shares. 
    Via InvestorPlace
    Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
    Spruce Biosciences' latest CAH studies: CAHmelia-203 & CAHptain-205. Discover insights on tildacerfont's efficacy, safety, and pharmacokinetics in adult & pediatric CAH patients. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Is Fisker (FSR) Stock Down 41% Today?
    Fisker stock is falling hard on Thursday as FSR investors react to reports that the EV company is preparing to file for bankruptcy. 
    Via InvestorPlace
    Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?
    Spruce Biosciences stock is falling hard on Thursday as investors in SPRB shares react to the latest clinical trial data reported. 
    Via InvestorPlace
    Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning! 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.